Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07206862) titled 'CHEMfoot: DEBRICHEM(R) in Chronic Diabetic Foot Wounds' on Sept. 25.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Outcomes Assessor).

Primary Sponsor: DEBx Medical B.V.

Condition: Diabetic Foot Ulcer (DFU) Diabetic Foot Ulcer Treatment Diabetic Foot Wounds

Intervention: Device: DEBRICHEM(R)

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: October 2025

Target Sample Size: 242

To know more, visit https://clinicaltrials.gov/study/NCT07206862

Published by HT Digital Content Serv...